Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr;23(4):595-596.
doi: 10.1111/1756-185X.13827.

Is paracetamol better than placebo for knee and hip osteoarthritis? A Cochrane review summary with commentary

Francesco Negrini  1 , Stefano Negrini  1   2
Affiliations
Comment

Is paracetamol better than placebo for knee and hip osteoarthritis? A Cochrane review summary with commentary

Francesco Negrini et al. Int J Rheum Dis. 2020 Apr.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Int J Rheum Dis. 2020 Jun;23(6):840. doi: 10.1111/1756-185X.13858. Int J Rheum Dis. 2020. PMID: 32573123 No abstract available.
No abstract available

PubMed Disclaimer

Comment on

  • Paracetamol versus placebo for knee and hip osteoarthritis.
    Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, Hunter DJ, Ferreira ML. Leopoldino AO, et al. Cochrane Database Syst Rev. 2019 Feb 25;2(2):CD013273. doi: 10.1002/14651858.CD013273. Cochrane Database Syst Rev. 2019. PMID: 30801133 Free PMC article.

References

REFERENCES

    1. Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2:CD013273.
    1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323-1330.
    1. Prior MJ, Harrison DD, Frustaci ME. A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Curr Med Res Opin. 2014;30(11):2377-2387.
    1. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465-474.
    1. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64(5):669-681.

LinkOut - more resources